Zoetis raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals.

Shares in Zoetis (NYSE:ZTS) edged higher in premarket US trading on Monday after the drugmaker reported ...

Zoetis saw notable growth in both companion animal and livestock segments.

LakeShore Biopharma has received approval for a Phase III clinical trial in China to test a simplified four-dose regimen of its YSJA rabies vaccine, potentially enhancing patient adherence and ...

“Rabies vaccines for dogs and cats are proven and ... “Annual boosters are recommended in high-risk areas. “Zoetis advises to discuss your pet’s vaccination schedule with your veterinarian ...

“Rabies vaccines for dogs and cats are proven and ... “Annual boosters are advised in high-risk areas. Zoetis encourages pet owners to consult their vet or state veterinarian regarding their ...

Rodney E. Rohde, Texas State University and Charles Rupprecht, Auburn University (THE CONVERSATION) Rabies is a deadly disease. Without vaccination, a rabies infection is nearly 100% fatal once ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 ...

JOHANNESBURG - World Rabies Day is on Saturday and this year's theme, 'Breaking Boundaries', encourages vaccination as the ... Lead at Companion Animals at Zoetis Inc discussed this with eNCA.

Zoetis Inc. (ZTS), headquartered in Parsippany, New Jersey, is a global leader in animal health. It specializes in the development, manufacturing, and distribution of medicines, vaccines ...

Zoetis Inc. (ZTS), headquartered in Parsippany, New Jersey, is a global leader in animal health. It specializes in the development, manufacturing, and distribution of medicines, vaccines ...